Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation

  1. Anitha P Govind
  2. Yolanda F Vallejo
  3. Jacob R Stolz
  4. Jing-Zhi Yan
  5. Geoffrey T Swanson
  6. William N Green  Is a corresponding author
  1. University of Chicago, United States
  2. National Institute of Dental and Craniofacial Research, National Institutes of Health, United States
  3. Northwestern University, Feinberg School of Medicine, United States

Abstract

To better understand smoking cessation, we examined the actions of varenicline (Chantix) during long-term nicotine exposure. Varenicline reduced nicotine upregulation of α4β2-type nicotinic receptors (α4β2Rs) in live cells and neurons, but not for membrane preparations. Effects on upregulation depended on intracellular pH homeostasis and were not observed if acidic pH in intracellular compartments was neutralized. Varenicline was trapped as a weak base in acidic compartments and slowly released, blocking 125I-epibatidine binding and desensitizing α4β2Rs. Epibatidine itself was trapped; 125I-epibatidine slow release from acidic vesicles was directly measured and required the presence of α4β2Rs. Nicotine exposure increased epibatidine trapping by increasing the numbers of acidic vesicles containing α4β2Rs. We conclude that varenicline as a smoking cessation agent differs from nicotine through trapping in α4β2R-containing acidic vesicles that is selective and nicotine-regulated. Our results provide a new paradigm for how smoking cessation occurs and suggest how more effective smoking cessation reagents can be designed.

Article and author information

Author details

  1. Anitha P Govind

    Department of Neurobiology, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Yolanda F Vallejo

    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Jacob R Stolz

    Department of Pharmacology, Northwestern University, Feinberg School of Medicine, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jing-Zhi Yan

    Department of Pharmacology, Northwestern University, Feinberg School of Medicine, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Geoffrey T Swanson

    Department of Pharmacology, Northwestern University, Feinberg School of Medicine, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. William N Green

    Department of Neurobiology, University of Chicago, Chicago, United States
    For correspondence
    wgreen@uchicago.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2167-1391

Funding

National Institutes of Health (RO1DA 035430)

  • Anitha P Govind
  • Yolanda F Vallejo
  • Jacob R Stolz
  • Jing-Zhi Yan
  • Geoffrey T Swanson
  • William N Green

University of Chicago (Cance center-Pilot grant)

  • Anitha P Govind
  • William N Green

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard Aldrich, The University of Texas at Austin, United States

Publication history

  1. Received: February 2, 2017
  2. Accepted: July 3, 2017
  3. Accepted Manuscript published: July 18, 2017 (version 1)
  4. Version of Record published: August 7, 2017 (version 2)

Copyright

© 2017, Govind et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,229
    Page views
  • 132
    Downloads
  • 9
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anitha P Govind
  2. Yolanda F Vallejo
  3. Jacob R Stolz
  4. Jing-Zhi Yan
  5. Geoffrey T Swanson
  6. William N Green
(2017)
Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation
eLife 6:e25651.
https://doi.org/10.7554/eLife.25651

Further reading

    1. Neuroscience
    Simon Desch, Petra Schweinhardt ... Susanne Becker
    Research Article

    Relief of ongoing pain is a potent motivator of behavior, directing actions to escape from or reduce potentially harmful stimuli. Whereas endogenous modulation of pain events is well characterized, relatively little is known about the modulation of pain relief and its corresponding neurochemical basis. Here we studied pain modulation during a probabilistic relief-seeking task (a 'wheel of fortune' gambling task), in which people actively or passively received reduction of a tonic thermal pain stimulus. We found that relief perception was enhanced by active decisions and unpredictability, and greater in high novelty-seeking trait individuals, consistent with a model in which relief is tuned by its informational content. We then probed the roles of dopaminergic and opioidergic signaling, both of which are implicated in relief processing, by embedding the task in a double-blinded cross-over design with administration of the dopamine precursor levodopa and the opioid receptor antagonist naltrexone. We found that levodopa enhanced each of these information-specific aspects of relief modulation but no significant effects of the opioidergic manipulation. These results show that dopaminergic signaling has a key role in modulating the perception of pain relief to optimize motivation and behavior.

    1. Genetics and Genomics
    2. Neuroscience
    Colleen M Palmateer, Catherina Artikis ... Michelle N Arbeitman
    Research Article

    Drosophila melanogaster reproductive behaviors are orchestrated by fruitless neurons. We performed single-cell RNA-sequencing on pupal neurons that produce sex-specifically spliced fru transcripts, the fru P1-expressing neurons. Uniform Manifold Approximation and Projection (UMAP) with clustering generates an atlas containing 113 clusters. While the male and female neurons overlap in UMAP space, more than half the clusters have sex differences in neuron number, and nearly all clusters display sex-differential expression. Based on an examination of enriched marker genes, we annotate clusters as circadian clock neurons, mushroom body Kenyon cell neurons, neurotransmitter- and/or neuropeptide-producing, and those that express doublesex. Marker gene analyses also show that genes that encode members of the immunoglobulin superfamily of cell adhesion molecules, transcription factors, neuropeptides, neuropeptide receptors, and Wnts have unique patterns of enriched expression across the clusters. In vivo spatial gene expression links to the clusters are examined. A functional analysis of fru P1 circadian neurons shows they have dimorphic roles in activity and period length. Given that most clusters are comprised of male and female neurons indicates that the sexes have fru P1 neurons with common gene expression programs. Sex-specific expression is overlaid on this program, to build the potential for vastly different sex-specific behaviors.